Robertson Stephens Wealth Management LLC decreased its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 8.8% during the 3rd quarter, HoldingsChannel reports. The firm owned 3,794 shares of the healthcare conglomerate’s stock after selling 367 shares during the period. Robertson Stephens Wealth Management LLC’s holdings in UnitedHealth Group were worth $1,482,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds and other institutional investors also recently made changes to their positions in the stock. RPg Family Wealth Advisory LLC acquired a new position in shares of UnitedHealth Group in the 2nd quarter worth $26,000. Mitsubishi UFJ Morgan Stanley Securities Co. Ltd. acquired a new stake in shares of UnitedHealth Group in the second quarter worth about $28,000. Activest Wealth Management acquired a new position in shares of UnitedHealth Group during the 2nd quarter worth about $29,000. Tompkins Financial Corp acquired a new position in shares of UnitedHealth Group during the 3rd quarter worth about $32,000. Finally, Annapolis Financial Services LLC increased its stake in UnitedHealth Group by 57.9% during the third quarter. Annapolis Financial Services LLC now owns 90 shares of the healthcare conglomerate’s stock valued at $35,000 after acquiring an additional 33 shares during the period. 86.20% of the stock is currently owned by institutional investors and hedge funds.
In related news, Director Richard T. Burke sold 2,500 shares of the business’s stock in a transaction that occurred on Tuesday, November 23rd. The shares were sold at an average price of $444.70, for a total transaction of $1,111,750.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Stephen J. Hemsley sold 75,000 shares of the business’s stock in a transaction on Monday, October 25th. The stock was sold at an average price of $448.72, for a total transaction of $33,654,000.00. The disclosure for this sale can be found here. 0.55% of the stock is currently owned by company insiders.
UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Thursday, October 14th. The healthcare conglomerate reported $4.52 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $4.41 by $0.11. UnitedHealth Group had a net margin of 5.52% and a return on equity of 23.08%. The firm had revenue of $72.34 billion for the quarter, compared to analysts’ expectations of $71.24 billion. During the same quarter last year, the company posted $3.51 EPS. The business’s quarterly revenue was up 11.1% on a year-over-year basis. Analysts predict that UnitedHealth Group Incorporated will post 18.84 earnings per share for the current year.
The firm also recently announced a quarterly dividend, which was paid on Tuesday, December 14th. Investors of record on Monday, December 6th were issued a dividend of $1.45 per share. This represents a $5.80 annualized dividend and a dividend yield of 1.23%. The ex-dividend date was Friday, December 3rd. UnitedHealth Group’s dividend payout ratio is currently 35.98%.
UNH has been the topic of a number of research analyst reports. The Goldman Sachs Group began coverage on UnitedHealth Group in a research report on Tuesday, December 14th. They set a “buy” rating and a $535.00 price target on the stock. UBS Group upped their price objective on shares of UnitedHealth Group from $435.00 to $452.00 and gave the company a “neutral” rating in a research report on Wednesday, December 1st. They noted that the move was a valuation call. Edward Jones started coverage on UnitedHealth Group in a report on Monday. They set a “buy” rating for the company. BMO Capital Markets raised their target price on shares of UnitedHealth Group from $475.00 to $500.00 and gave the company a “market perform” rating in a research note on Thursday, December 2nd. They noted that the move was a valuation call. Finally, Zacks Investment Research raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $477.00 price objective on the stock in a research note on Wednesday, October 27th. Two analysts have rated the stock with a hold rating, twenty-two have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Buy” and a consensus target price of $500.54.
UnitedHealth Group Company Profile
UnitedHealth Group, Inc engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum’s capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience.
Read More: Percentage Gainers
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.